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Purpose: Multi-leaf collimator (MLC) tracking radiotherapy is complex as the beam pattern
needs to be modied due to the planned intensity modulation as well as the real-time target10
motion. The target motion cannot be planned, therefore the modied beam pattern diers
from the original plan and the MLC sequence needs to be recomputed online. Current
MLC tracking algorithms use a greedy heuristic in that they optimize for a given time, but
ignore past errors. To overcome this problem, we have developed and improved an algorithm
that minimizes large underdose and overdose regions. Additionally, previous underdose and15
overdose events are taken into account to avoid regions with high quantity of dose events.
Methods: We improved the existing MLC motion control algorithm by introducing a cu-
mulative underdose/overdose map. This map represents the actual projection of the planned
tumor shape and logs occurring dose events at each specic regions. These events have an
impact on the dose cost calculation and reduce recurrence of dose events at each region. We20
studied the improvement of the new temporal optimization algorithm in terms of the L1-norm
minimization of the sum of overdose and underdose compared to not accounting for previous
dose events. For evaluation, we simulated the delivery of 5 conformal and 14 IMRT-plans
with 7 3D patient measured tumor motion traces.
Results: Simulations with conformal shapes showed an improvement of L1-norm up to 8:5%25
after 100 MLC modication steps. Experiments showed comparable improvements with the
same type of treatment plans.
Conclusion: A novel leaf sequencing optimization algorithm which considers previous dose
events for MLC tracking radiotherapy has been developed and investigated. Reductions in
underdose/overdose are observed for conformal and IMRT delivery.30
I. INTRODUCTION
Radiation therapy aims to control the cell growth of
tumor targets by delivering radiation dose to the target.
To spare healthy tissue during treatment, high precision
of the beam delivery and the beam shape is required,35
but anatomical motion during treatment causes misalign-
ment between anatomy and beam shape. To reduce this
intrafractional misalignment, tumor tracking has been in-
troduced to synchronize the beam shape with the tumor
motion1{6. This synchronization is done by modifying40
the position of the beam during treatment.
Intrafractional target motion in MLC tracking radio-
therapy requires the MLC to deliver online modied
beam shapes. These shapes are dierent from the previ-
ous planned tumor shapes. After the target has moved45
during treatment and the new position is detected in real
time, the MLC adapts the planned shape and delivers a
modied beam shape. Managing complex motion pat-
tern as well as complex beam shapes demand a system-
atic approach for MLC adaptation. Additionally, this50
shape adaption results in three dierent types of MLC
aperture errors7. The rst error, which due to the tar-
get position can only be estimated, is called localization
error. Second, the leaf tting errors are caused by the
nite leaf width and nally, the leaf adjustment errors55
are due to the nite leaf speed. Full-edged re-planning
in real-time would be the most ideal solution to over-
come these problems. However, this is impractical due
to heavy computation and on as-yet unresolved quality
assurance issue8,9.60
In this work, we expand the rst order approxima-
tion to ideal online re-planning introduced by Ruan and
Keall10. In this rst order optimization approach, the
MLC leaf conguration is adapted by calculating the
optimal leaf pair position according to the current tu-65
mor position. In this setup, undeliverable shapes occur,
e.g. undeliverable shapes occur when the shape partially
overlaps a leaf pair. In this case the leaves can be fully
closed, which underdoses the edge of the tumor, or fully
open which overdoses healthy tissue. These undeliverable70
shapes result in overdose and underdose events, which we
will refer to as dose events, caused by the aperture er-
rors introduced above. Further events appear, since the
target is continuously moving while the framework cal-
2culates the new MLC setup and the leaves are adapting75
to the new positions. To minimize the MLC aperture
errors and the resulting dose events, we use previous un-
derdose and overdose information in our improved leaf
sequencing optimization algorithm to calculate the opti-
mal new shape. This technical note introduces a novel80
optimization framework expansion.
II. MATERIAL AND METHODS
We formulated the optimization problem in a con-
strained optimization algorithm with a dose map as in-
put. In this dose map, all previous overdose and un-85
derdose events are recorded with their specic position.
The optimization algorithm calculates the leaf sequence
parameters that minimize the integrated overdose and
underdose cost over all regions from the beginning of
treatment till the actual time step, i.e. the optimization90
process is minimizing the L1-norm of the cumulative dose
error. The optimal solution is derived by shifting the
overdose/underdose map according to the detected in-
trafractional target displacement and including the previ-
ous occurred dose error in the optimization process. The95
separability of the cost across various leaf tracks allows
us to improve the eciency of the optimization algorithm
and to consider each leaf track independently. We inte-
grated the algorithm into an existing in-house developed
framework11.100
II.A. Mathematical Optimization Formulation
This section discusses the leaf sequencing optimization
problem in the presence of motion. We assume a given
tumor shape f(x; y) and an estimated anatomical motion
pattern T (t), collapsed onto the beam's eye view (BEV).105
The ideal motion-compensated shape g is given by com-
bining f(x; y) with the collapsed BEV motion, resulting
in the function g = f  T . The (x,y)-plane is located in
the BEV, see gure 1.
The function g(x; y; t), where (x; y) denotes the ele-
ment location at a certain time point t, can be seen
as a binary function over the region-of-interest (ROI):

! f0; 1g, so that
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(
1 (x; y; t) 2 transformed shape opening
0 else
Without loss of generality, we align the x-coordinate with110
the leaf track direction. Let  be the leaf resolution
and located along y-direction. The complete aperture
consists of N leaf pairs, starting at y = 0. With these
specications, the optimization problem can be described
as: nding the optimal position for every leaf pair, which115
ts the transformed tumor shape at a specic time point
 best and takes previous overdose and underdose events
into account.
The leaf pair positions are parametrized as Li for the
left leaf position and Ri for the right leaf position, where
y
z
x
R(xp; yp; ziso; t)
g(x; y; t)
Fig. 1 This shows the basic setup. The MLC is located between
treatment beam and target R(xp; yp; ziso; t).
the index i = 1; 2; :::; N describes the leaf pair. The op-
timization objective is quantitatively dened as the dis-
crepancy between the deliverable shape parametrized by
fLi; RigNi=1 and the requested transformed tumor shape
g(x; y; t). Motivated by the therapeutic intent, this dis-
crepancy is characterized as the sum of underdose and
overdose costs,
P
u(x; y) and
P
o(x; y), respectively.
For the tumor shape, the underdose cost tumoru (x; y)
is essential and initialized with 1, while the overdose
tumoro (x; y) is 0 and for the radio-sensitive healthy tissue
the overdose cost tissueo (x; y) becomes important and is
initialized with 1 while the underdose tissueu (x; y) is set
to 0. Underdose and overdose cost can be combined to
a -map. These maps o and u contain the overdose
and underdose events of every treatment step. Therefore
the optimization problem aims to nd the Li/Ri position
for every leaf pair i, which minimizes the overall sum of
overdose cost i;o and underdose cost i;u considering
actual and previous overdose and underdose events
min
X
i
X
t
(i;o(t) + i;u(t)):
To take previous overdose and underdose events into
account, the cost maps o and u are time dependent and120
'collect' all occurring overdose and underdose events by
increasing the weighting at this point (x; y) by 1. Assum-
ing the leaves are of widths , then the underdose cost
and overdose cost for leaf track i are given at a certain
point of time  by125
i;u() =
R i
(i 1)
R xmax
0
 R 
0
u(x; y; t)dt

g(x; y; ) [I(Li   x) + I(x Ri)] dxdy
3and
i;o() =
R i
(i 1)
R xmax
0
 R 
0
o(x; y; t)dt

(1  g(x; y; )) [I(x  Li)I(Ri   x)] dxdy;
Fig. 2 This is an example of an initialized underdose/overdose
map. The planned tumor shape is white, while the shape that is
not meant to be treated is black.
while I is the indicator function and the following opti-
mization needs to be solved
mini() = min (i;u() + i;o()):
For simplicity, we ignore in this mathematical descrip-
tion the leaf velocity. This condition can be included by
introducing additional constraints on the optimization
process.
Due to the fact that only  and g are dependent on y130
and both are independent of Li and Ri, we can reduce
the cost functions to one dimension
i;u() =
Z xmax
0
ci;u(x; ) [I(Li   x) + I(x Ri)] dx
and
i;o() =
Z xmax
0
ci;o(x; ) [I(x  Li)I(Ri   x)] dx;
where the function c(x; ) includes
ci;u(x; ) =
Z i
(i 1)
Z 
0
u(x; y; t)dt

g(x; y; )dy
as well as
ci;o(x; ) =
Z i
(i 1)
Z 
0
o(x; y; t)dt

(1  g(x; y; )) dy:
The function c(x; ) includes the information of the -
map and can be understood as a weighting factor for a
specic position x, while () provides the optimal Li-135
and Ri-leaf position.
II.B. Solving the Optimization Problem
We implemented this optimization process in our exist-
ing treatment framework and without any restriction we
can combine both -maps to an underdose/overdose map140
where the overdose areas of the radio-sensitive tissue are
initialized with +1, while the underdose areas of the tu-
mor shape are initialized with  1, see gure 2. Occurring
underdose or overdose events increase the value in the145
map by  1 or +1 respectively at the occurring position
(x; y). To ensure that the global minimum of the prob-
lem is found, we expand the optimization formula with
its variance.
Therefore, the optimization formula is split into three
cases and formulated as:
min0i() = min
 
i;1()
2 +i;2()
2 +i;3()
2

;
with
i;1() =
Z Li
0
ci;u(x; )dx;
i;2() =
Z Ri
Li
ci;o(x; )dx
and
i;3() =
Z xmax
Ri
ci;u(x; )dx;
where i;1() and i;3() describe the underdose cost as-
sociated with the region covered by the left and right leaf
respectively and i;2() describes the overdose cost be-
tween the two leaves. The left and right leaf position are
only related by the constraint that Li  Ri. Therefore,
the rst order condition for optimality is
@
@(Li)
0ijLi=x = 0;
@
@(Ri)
0ijRi=x = 0;
and the second order condition becomes
@2
@(Li)2
0ijLi=x > 0;
@2
@(Ri)2
0ijRi=x > 0:
II.C. Experiments150
To reduce the complexity of the problem, we started to
implement our algorithm for 2D step and shoot intensity-
modulated radiotherapy (IMRT), where we only needed
a 2D--map. We simulated the delivery of ve conformal
and fourteen IMRT-plans with seven 3D patient mea-155
sured tumor motion traces. We simulated 100 MLC mod-
ication steps and evaluated the eciency of our leaf se-
quencing optimization algorithm by calculating the mean
absolute dose error (L1-norm), as well as the increase of
the mean absolute error (MAE) at every step for the160
resulting 2D--map. We used patient planned shapes
for our simulations, therefore the shapes were simple in
their complexity, which means that the planned treat-
ment shape is aligned to the MLC and in absence of tu-
mor motion the shape can be perfectly reproduced by the165
MLC. To increase the complexity of the shapes during
simulation, we also rotated the shapes by 90 to obtain
extreme shapes that cannot be perfectly reproduced by
the MLC. This 90 rotation is not likely to occur clini-
cally, but if we nd an improvement for this extreme case170
we make sure that in the whole interval from 0 to 90
rotations improvement can be reached. To conrm our
simulated results, we performed IMRT experiments at a
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Fig. 3 This is a patients measured motion trace we used for our
experiments at the Varian Clinac machine.
Table I This table shows simulation results for two dierent kind
of shapes with ve dierent displacement amplitudes. All simula-
tions are performed with the greedy heuristic algorithm by10 and
with our new temporally optimized algorithm. The mean absolute
error (MAE) is calculated after 100 optimizations and the MAE
increase displays the average L1-norm increase per step.
Amp Rot MAE MAE MAE step MAE step
No [mm] [deg] greedy temporal increase increase
heuristic optimized greedy optimized
1 35 0 1.79 1.77 0.0067 0.0065
2 30 0 1.70 1.68 0.0069 0.0066
3 25 0 1.71 1.68 0.0065 0.0063
4 15 0 1.71 1.69 0.0064 0.0062
5 15 90 1.84 1.77 0.0079 0.0072
6 00 90 1.97 1.80 0.0092 0.0075
Varian Clinac machine. For these experiments, we used
one 3D patient planned tumor shape and two 3D patient175
measured tumor motion traces; one trace is shown in
gure 3. The delivered dose information were measured
by our framework, we logged the actual and needed leave
positions, delivered dose and the -map. Using this infor-
mation we were able to evaluate the improvement of our180
optimization algorithm without the need for a phantom.
The time interval of motion tracking is 40 ms, therefore
our optimized leaf positions need to be calculated in this
time period.185
III. RESULTS
Simulations of conformal shapes showed an improve-
ment of L1-norm up to 8:5% after 100 MLC modication
steps. The improvement in terms of L1-norm for a sin-
gle step increased by up to 18:2%. For every simulated190
case, an improvement of MAE can be achieved. As it
can be seen in table I, the improvement of MAE varies
between simulation setups. For shapes that are aligned
to the MLC, the improvement of our algorithm is about
1:45 0:1%, because our algorithm improvements apply195
only for the case when the shape is exactly shifted by half
of the leaf width. For more complex shapes the improve-
ment gets much larger, as for every single optimization
step previous dose events aect the optimization result.200
Experiments on a Varian Clinac machine conrmed our
Table II This table shows experiment results of IMRT treatment
with a maximum displacement of 16.9 mm. All experiments are
performed with the greedy heuristic algorithm by10 and with our
new temporally optimized algorithm. No. 1 used a prostate treat-
ment plan, while the others used a lung tumor plan.
Amp MAE MAE MAE step MAE step
No avg greedy temporal increase increase
[mm] heuristic optimized greedy optimized
1 2.53 0.287 0.283 0.0031 0.0028
2 2.53 0.342 0.318 0.0040 0.0032
3 2.53 0.247 0.214 0.0025 0.0021
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Fig. 4 This overdose/underdose map shows results after 100 steps
for the IMRT experiments. In the large gray areas no dose events
have occured, while in the lighter areas overdose and in the darker
areas underdose events happened.
simulated results, see table II. Numeral experiments with
IMRT showed an improvement of up to 1:4% after the
rst 100 steps for prostate and up to 7:0% for lung treat-205
ments. For a single step, the average MAE improvement
was 3:28  0:4% of all prostate treatment experiments.
This improvement corresponds with our simulations and
our expected improvement for simple shapes.210
The runtime of our algorithm was on average 23:74 ms,
but some cases were over 120 ms. The larger runtime
can be reduced by running the optimization for separate
leaves in parallel. The overall latency of tumor tracking
systems is of the order of 200-300 ms and 23.74 ms is215
comparable to existing systems2{7.
IV. CONCLUSION
A novel leaf sequencing optimization algorithm which
considers previous dose events for MLC tracking radio-
therapy has been developed and investigated. Reductions220
in underdose and overdose are observed for conformal
and IMRT delivery. Our algorithm shows only a modest
improvement when rotation is ignored, with a more sig-
nicant improvement when rotation is included. Further
improvements are expected as we transition to tracking225
general shapes, such as the uence map produced during
treatment planning. In this work we have assumed that
5the treatment plan and uence map remain invariant to
patient motion. Online treatment re-planning that takes
into account leaf velocities, previous underdose/overdose230
and the predicted tumor motion is the next logical step
in tumor tracking software. Online re-planning remains
a challenge because of computation time and potential
issues with QA and RT acceptance. The next step to
improve our algorithm will be to extend and test it for235
volumetric intensity modulated arc therapy. Here a 3D-
-map is needed, where for every treatment angle the
corresponding 2D--map is calculated using forward and
backward projection. A 3D leaf sequencing optimization
algorithm which considers previous underdose and over-240
dose events could allow to use the planning target volume
(PTV) or the clinical target volume (CTV) with internal
margin as input for function f(x; y). This would poten-
tially further reduce the dose errors while increasing the
treatment accuracy, and is the rst step to online treat-245
ment planning. In the future, we plan to improve our
MLC motion control algorithm in terms of L1-norm dose
error minimization by using more realistic and conformal
shapes in the optimization process. We also plan to in-
crease the robustness of the algorithm by optimizing the250
algorithm latency. Additionally, it is possible to include a
L2-norm minimization into the algorithm to reduce over-
dose and underdose peaks in the patient.
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